Acerta Pharma B.V. A member of the AstraZeneca Group

About Acerta Pharma B.V. A member of the AstraZeneca Group

Acerta Pharma is a European R&D centre of the AstraZeneca group dedicated to the discovery and development of novel innovative drugs for the treatment of haematological malignancies.

The company began operations in 2013 with the vision of combining cutting edge science, unique covalent technology, and an experienced, dedicated team in order to deliver novel targeted therapies for patients with cancer. In 2016 AstraZeneca took a majority stake in the company and Acerta Pharma was fully acquired by AstraZeneca in 2021.

We are working to develop new treatment options for patients with specific types of blood cancer. Together with our R&D colleagues of AstraZeneca in Gaithersburg, San Francisco, Boston (US), Gothenburg (SE) and Cambridge (UK) we are committed to innovative drug discovery and development, especially in the field of haematological oncology.

Keywords

• Hematology
• Oncology

Address

• Headquarters

  Kloosterstraat 95349AB OssNoord-Brabant, Netherlands

Team by function

Based on 95 public job profiles as of 4 September 2026.

• Research / R&D62
• Other / Unclassifiable17
• Healthcare / Medical7
• Operations3
• HR / People / Recruiting2
• Administrative / Office1
• Executive / C-Suite1
• IT / Infrastructure / Security1
• Product Management1